HypoglycemiaHyperglycemiaBlood GlucoseInsulinDiabetic KetoacidosisInsulin ComaHypoglycemic AgentsDiabetes Mellitus, Type 1Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hemoglobin A, GlycosylatedDiabetes MellitusInsulin, Long-ActingIslets of LangerhansInsulin Infusion SystemsBlood Glucose Self-MonitoringGlucoseGlucagonHyperinsulinismInsulin, Regular, PorkInsulin LisproGliclazideInfusions, SubcutaneousGlucose Clamp TechniqueCongenital HyperinsulinismSulfonylurea CompoundsInsulin, IsophaneEpinephrineStreptozocinGlucose Tolerance TestInsulin AntibodiesCritical IllnessDiabetic AngiopathiesPancreatic PolypeptideC-PeptideIslets of Langerhans TransplantationAwarenessMetforminFastingGluconeogenesisRisk FactorsTime FactorsComaPostprandial PeriodRetrospective StudiesInsulin-Secreting CellsClinical AlarmsRats, Sprague-DawleySeverity of Illness IndexTreatment OutcomeInsulin ResistanceGlucokinaseDiabetes ComplicationsDrug Administration ScheduleVentromedial Hypothalamic NucleusInjections, SubcutaneousHydrocortisoneSeizuresPregnancy in DiabeticsGlycosuriaBrain DiseasesInsulinomaBrainPancreas, ArtificialNesidioblastosisCognitionGlipizidePhlorhizinFatty Acids, NonesterifiedLiverGlucagon-Like Peptide 1HomeostasisPancreasBody WeightNorepinephrineDiazoxideIncidenceGlucose Intolerance3-Hydroxybutyric AcidInfusions, IntravenousReference ValuesDiabetic NephropathiesRats, WistarPancreatectomyProspective StudiesDipeptidyl-Peptidase IV InhibitorsDiabetic NeuropathiesAcarboseFollow-Up StudiesInsulin AspartGlucagon-Secreting CellsDisease Models, AnimalLactatesLactic AcidGlycogenDiabetic ComaMonitoring, AmbulatorySomatostatinHyperglycemic Hyperosmolar Nonketotic ComaLiver Glycogen